Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Glenmark Pharmaceuticals Limited Press Release Jul 21 2026

· Issued by Glenmark Pharmaceuticals Limited via NSE India

Filed with NSE · · 4 pages · English

On 6ix: 6ix.com/news/glenmark-pharmaceuticals-limited-press-release-jul-21-2026

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 21, 2026, titled "Glenmark Receives U.S. FDA Approval to Expand the Use of RYALTRIS® Nasal Spray for Children Aged 6 to Less Than 12 Years".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases